EcoDrugPlus

Presenilin 1

Ensembl ID : ENSNGAG00000017181
Gene Symbol: PSEN1
3 Cross references
200 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSNGAG00000023668
Gene Symbol: PSEN2
3 Cross references
205 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSNGAG00000007907
Gene Symbol: PSENEN
3 Cross references
183 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSNGAG00000022362
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSNGAG00000019341
Gene Symbol: PTGDR
3 Cross references
118 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSNGAG00000020300
Gene Symbol: PTGDR2
3 Cross references
206 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSNGAG00000015906
Gene Symbol: PTGER1
3 Cross references
235 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSNGAG00000016331
Gene Symbol: PTGER2
3 Cross references
241 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSNGAG00000014963
Gene Symbol: PTGER3
3 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSNGAG00000002797
Gene Symbol: PTGER4
3 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSNGAG00000000646
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSNGAG00000015456
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).